20,707
Participants
Start Date
January 30, 2023
Primary Completion Date
July 15, 2024
Study Completion Date
July 15, 2024
AI-assisted MatchMiner Platform
A medical record data analysis tool that uses conjunction machine learning and natural language processing models to predict changes in treatment and prognosis and ascertain progression of disease and metastatic sites using retrospective imaging reports. MatchMiner is an established clinical operations tool at Dana-Farber Cancer Institute that links OncoPanel next-generation sequencing data to basic clinical information and clinical trial eligibility criteria to suggest biomarker-selected therapeutic trials for participants.
Dana-Farber Cancer Institute, Boston
National Cancer Institute (NCI)
NIH
Dana-Farber Cancer Institute
OTHER